Company News

Company News

Stay updated with our latest developments, industry insights, and company milestones.

Home News
Latest Updates
7 Articles
The key targets for obesity and diabetes: GLP-1R, GIPR and GCGR 2026-06-24

The key targets for obesity and diabetes: GLP-1R, GIPR and GCGR

Read More
FDA Announces Public Meeting on Dietary Supplement Innovation and the Scope of Dietary Ingredients 2026-06-24

FDA Announces Public Meeting on Dietary Supplement Innovation and the Scope of Dietary Ingredients

Read More
How to Report a Problem with Dietary Supplements 2026-06-24

How to Report a Problem with Dietary Supplements

Read More
A single pill from Eli Lilly has pushed the weight-loss drug 2026-06-24

A single pill from Eli Lilly has pushed the weight-loss drug "Warrior" into the second half of its campaign.

Read More
$36.5 billion! Tirzepatide has officially surpassed Semaglutide and has taken the top spot as the world's most valuabl. 2026-06-24

$36.5 billion! Tirzepatide has officially surpassed Semaglutide and has taken the top spot as the world's most valuabl.

Read More
Are Peptides Legal in the EU and UK?  2026-04-13

Are Peptides Legal in the EU and UK? 

Read More
U.S. Supplement Sales Hit $72.88 Billion as Sports Nutrition and Digital Discovery Drive Growth 2026-03-23

U.S. Supplement Sales Hit $72.88 Billion as Sports Nutrition and Digital Discovery Drive Growth

Read More